Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 927 of 6351
-
Can a smartphone app calm anxiety and protect the heart?
Symptom relief CompletedThe treatment of generalized anxiety disorder (GAD) in an accessible manner represents an unmet need for those with cardiovascular disease (CVD), given that patients with CVD experience numerous barriers for in-person treatment engagement. The research plan for the proposed pilot…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New shingles vaccine CRV-101 takes on shingrix in Head-to-Head trial
Vaccine OngoingThe purpose of this study is to assess the safety and immunogenicity of amezosvatein (CRV-101), an investigational vaccine compared to Shingrix® for the prevention of herpes zoster in adults aged 50 years and older
Phase 2 • Sponsor: Curevo Inc • Aim: Vaccine
Last updated Jun 27, 2026 07:53 UTC
-
Promising drug aims to stop Flare-Ups in rare brain disease
Disease control OngoingThe purpose of the study is to evalute the efficacy, safety and tolerability of rozanolixizumab for treatment of adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Housing instead of handcuffs: new trial for homeless with mental illness
Disease control OngoingPeople who are homeless with severe psychiatric disorders have to negotiate discontinuous mental health care pathways including high use of emergency departement and enforced hospitalisation, poor access to ambulatory care, poor access to common rights services and a greater risk…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Magnetic pulses aim to stabilize the wandering mind in lewy body dementia
Symptom relief Recruiting nowThe present study is a monocentric, therapeutic clinical trial involving forty patients diagnosed with Dementia with Lewy Bodies (DLB). The aim of this clinical trial is to evaluate the feasibility and relevance of repetitive transcranial magnetic stimulation (rTMS); a non-invasi…
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Weekly chemo may be gentler for head and neck cancer patients
Disease control PausedThis phase II/III trial compares whether cisplatin given weekly with radiation therapy is better tolerated than cisplatin given every three weeks with radiation therapy for the treatment of head and neck cancer that has spread to other places in the body (advanced). The second pa…
Phase 2/3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Your digital twin could help beat diabetes
Disease control OngoingThis is a randomized study comparing outcomes of patients diagnosed with Type 2 Diabetes (T2D) who are enrolled into the Twin Health Precision Treatment (TPT) system versus usual care. The study will last for a year with a 1 year optional extension for the TPT arm patients to con…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 26, 2026 17:33 UTC
-
AI could uncover hidden lung disease in routine chest X-Rays
Diagnosis CompletedThe goal of this observational study is to learn how well an artificial intelligence (AI)-based chest X-ray analysis software can incidentally detect interstitial lung disease (ILD), which appears as interstitial opacity, on chest X-rays taken for other reasons, and whether these…
Sponsor: Chung-Ang University Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Can a structured care pathway ease teen depression?
Disease control Recruiting nowThis is a quasi-experimental, multi-site cluster controlled clinical trial design with two intervention arms--Treatment As Usual (TAU) and an Integrated Care Pathway (ICP). Eligible participants are between the ages of 13 and 18, who present to community mental health agencies wi…
Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New combo aims to stop leukemia return after transplant
Disease control Recruiting nowThe goal of this clinical research study is to learn if azacitidine combined with Chidamide will help to control the disease in patients with high-risk AML after an allogeneic stem cell transplant. The safety of this combination will also be studied.
Phase 1/2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Lymphoma patients may get a simpler shot option
Disease control OngoingThis study will evaluate the efficacy, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with selected B-cell malignancies (types of non-Hodgkin's lymphoma \[NHL\]).
Phase 2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
A bike ride could reveal hidden heart risks in young cancer survivors
Diagnosis CompletedThis study aims at investigating the feasibility of recruitment and application of a method regarding early detection of subclinical changes in cardiac health after completion of acute cancer treatment during childhood and adolescence.
Sponsor: Technical University of Munich • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
Could a simple vacuum dressing slash infection rates in sarcoma surgery?
Disease control Recruiting nowProject Summary - Aggressive soft tissue cancers are commonly treated with radiation followed by surgery. These wounds have a very high rate of wound complications and infection (30%), resulting in more surgeries, longer hospital stays and complex nursing care. Previous research …
Sponsor: Dr. J. Werier • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gene therapy for rare blood disease shows promise in Long-Term Follow-Up
Disease control By invitation onlyLong-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of RP-L102
Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New trial tests drug combo to keep ovarian cancer at bay
Disease control Recruiting nowRandomized, open label, phase II multicenter study to assess the efficacy niraparib versus niraparib +bevacizumab maintenance in patients with newly diagnosed stage IIIA/B/C high-grade epithelial ovarian cancer with no residual disease after frontline surgery and treatment by adj…
Phase 2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New implant zaps nerves to stop bladder leaks
Disease control CompletedThe purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.
Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo shows promise in shrinking breast tumors before surgery
Disease control OngoingThis study will test any good and bad effects of combining the study drugs pembrolizumab and olaparib, given before the standard surgical procedure, to treat TNBC or HR+ HER2- breast cancers. The study drugs could shrink cancer, but they could also cause side effects. The study r…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail shows promise in shrinking HER2+ stomach tumors before surgery
Disease control OngoingThis study is an open-label, single-arm, multicenter, Phase 2 study to evaluate the efficacy and safety of neoadjuvant chemotherapy with T-DXd monotherapy in patients with HER2-positive gastric cancer. In the combination cohort, the efficacy and safety of neoadjuvant chemotherap…
Phase 2 • Sponsor: National Cancer Center Hospital East • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New targeted pill shows promise for Hard-to-Treat lung cancer
Disease control Stopped earlyThe main objective of this study is to evaluate the tumor objective response rate (ORR) assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria in participants who receive sotorasib at either 960 mg daily or 240 mg daily whose tumors are programmed death-li…
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug combo offers hope for rare Pregnancy-Related cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of camrelizumab and apatinib as combination therapy in patients with ultra high-risk (Cohort A) and high-risk chemo-refractory or relapsed (Cohort B) gestational trophoblastic neoplasia (GTN). Eligible patients will…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC